Invest in Bavaria presents Bavaria as a top biotechnology location at the BIO International Convention 2011 in Washington, D.C. from June 27 to 30, 2011

The BIO International Convention, the largest biotechnology fair in the world, invites you to Washington, D.C. for this great event. Invest in Bavaria, the Business Promotion Agency of the State of Bavaria for foreign investors, will be at BIO 2011 providing information on Bavaria’s role as a top business location and its leading biotechnology cluster in Europe.

Bavaria has been consistently successful in building up and promoting leading research centers in the biotechnology and pharmaceutical industries. With its two elite universities, the State offers a world-class breeding ground for basic research and industry-oriented research in the fields of biotechnology, medicine and chemicals.

Such major biotech and pharmaceutical companies as 4SC, Amgen, Astellas Pharma, Biogen Idec, BMS, Daiichi Sankyo, GSK, Gilead, Novartis, MSD Sharp & Dohme, Medigene, Merck Serono, MorphoSys, Roche or Sanofi-Aventis have their German or their European branch offices in Bavaria. The opportunities available here for development are ideal for small and medium-sized life-science companies, including in many cases “spin-offs” from larger corporations or university research institutions.

Come to BIO 2011 for further information about the advantages that the biotech State of Bavaria has to offer and find out more about the opportunities and framework conditions of setting up a facility in Bavaria. You will find Invest in Bavaria on Booth No. 2323 in the German Pavilion.

Come and visit our booth!

We look forward to seeing you there.

Your contact:

Benjamin Emans

Senior Manager Life Sciences | Chemicals Industry

Tel.: +49 89 2162-2209

healthcare@invest-in-bavaria.com